杏林製薬株式会社 · Pharmaceutical · FY ends Mar
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | 日本マスタートラスト信託銀行株式会社 | 6,053,000 | 10.41% | ¥10.0B | ¥345M |
| 2 | Mycam Co., Ltd. | 5,178,000 | 8.90% | ¥8.5B | ¥295M |
| 3 | Lucius Co., Ltd. | 2,817,000 | 4.84% | ¥4.6B | ¥161M |
| 4 | 株式会社日本カストディ銀行 | 2,207,000 | 3.79% | ¥3.6B | ¥126M |
| 5 | キョーリン製薬グループ持株会 | 2,090,000 | 3.59% | ¥3.4B | ¥119M |
| 6 | BBH FOR THE ADVISORS’ INNERCIRCLE FUND II/KOPERNIK GLO ALL-CAP FUND | 1,995,000 | 3.43% | ¥3.3B | ¥114M |
| 7 | Banleena Co., Ltd. | 1,950,000 | 3.35% | ¥3.2B | ¥111M |
| 8 | Archans Co., Ltd. | 1,950,000 | 3.35% | ¥3.2B | ¥111M |
| 9 | Luches Co., Ltd. | 1,760,000 | 3.02% | ¥2.9B | ¥100M |
| 10 | Kakenken Pharmaceutical Co., Ltd. | 1,602,000 | 2.75% | ¥2.6B | ¥91.3M |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| 荻原 豊 | President & Representative Director | 79,063 | ¥130M | — |
| 大野田 道郎 | Director | 17,170 | ¥28.2M | — |
| 黒瀬 保至 | Director | 4,087 | ¥6.7M | — |
| 鹿内 徳行 | Director | 6,100 | ¥10.0M | — |
| 重松 健 | Director | 5,900 | ¥9.7M | — |
| 渡邉 弘美 | Director | 3,600 | ¥5.9M | — |
| 松本 臣春 | Full-time Audit & Supervisory Board Member | 22,000 | ¥36.2M | — |
| 阿久津 賢二 | Full-time Audit & Supervisory Board Member | 14,350 | ¥23.6M | — |
| 山口 隆央 | Audit & Supervisory Board Member | 3,300 | ¥5.4M | — |
| 池村 幸雄 | Audit & Supervisory Board Member | 1,300 | ¥2.1M | — |
| 森田 憲右 | Audit & Supervisory Board Member | 1,300 | ¥2.1M | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Mar 2026 | ¥1,645 | ¥60.03 | 27.4x | ¥57.0 | 59,945,641 |
| FY ending Mar 2025 | ¥1,503 | ¥158.17 | 9.5x | ¥57.0 | 64,607,936 |
| FY ending Mar 2024 | ¥1,812 | ¥92.74 | 19.5x | ¥52.0 | 64,607,936 |